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ABSTRACT
Objectives The Arabian Gulf region has limited
epidemiological data related to sexually transmitted
infections. The objective of this study was to estimate
the prevalence of Chlamydia trachomatis infection
among general population women in Doha, Qatar.
Methods Endocervical swabs were collected from
healthy women attending primary healthcare centres in
Doha, June–December 2008. The specimens were tested
for C trachomatis by a commercially available PCR-based
assay. Data on basic socio-demographic characteristics,
medical history and sexual behaviour were obtained
using self-administered questionnaires. The prevalence of
C trachomatis and of background variables were
stratified by nationality, Qatari nationals versus
non-Qatari residents.
Results A total of 377 women were enrolled in the
study, out of whom 351 (37.9% Qataris, 62.1% non-
Qataris) were tested for the presence of C trachomatis in
their specimens. The mean age of participants was
41.2 years, and the vast majority (93%, 95% CI 90.3 to
95.7) were married. The mean age at sexual debut was
significantly lower among Qatari women compared with
non-Qatari women (19.2 vs 22.2 years, respectively
p<0.001), but the mean number of reported lifetime
sexual partners (1.1 partner) was nearly the same in
both groups (p=0.110). The prevalence of C trachomatis
infection was 5.3% among Qatari women and 5.5%
among non-Qatari women, with no statistically
significant difference between both groups (p=0.923).
Conclusions The prevalence of C trachomatis among
women was higher than expected, with no significant
difference between Qatari nationals and expatriate
residents. The higher prevalence may reflect, in part, the
limited access to and use of chlamydia screening and
management.
INTRODUCTION
Data on the prevalence of Chlamydia trachomatis
infection in the Middle East and North Africa
(MENA) region remain scarce due to its limited
research capacity and sociocultural sensitivity
around sexually transmitted infections (STIs).1 2
This challenge is further compounded by methodo-
logical limitations in available studies and by the
logistical difficulty in conducting STI studies
among women.2 Considering that C trachomatis is
one of the most common curable bacterial STIs
worldwide,3 and given its complications in infected
women in terms of pelvic inflammatory disease,
infertility and ectopic pregnancy among others,3
there is a need to address the invisible and poorly
quantified disease burden of this infection in this
part of the world. Against this background, the
objective of the present study was to estimate the
prevalence of C trachomatis infection among
general population women in Qatar.
METHODOLOGY
Study design and participants
This was a cross-sectional study on healthy asymp-
tomatic ever-married women attending eight
women’s primary healthcare centres in the capital
city, Doha, for a routine Pap smear examination
during the period June to December 2008. A com-
ponent of this study was focused on studying
human papillomavirus epidemiology, and therefore,
centres were considered only if Pap smear examin-
ation was offered. More than 70% of the total
population of Qatar are non-Qatari,4 but Qataris
were the primary target population for this study.
Based on the advice of the Qatar Supreme Council
of Health, these centres were chosen as they are
frequented by Qatari nationals and offer Pap smear
examination. The centres represent the core of
primary healthcare services in Qatar serving over a
million attendees per year within the women’s
clinics and the other clinics. All Qatari and resident
non-Qatari women have access to these centres and
the services are covered by the national health
insurance programme. All the centres are in urban
settings, and they cover both primary care as well
as follow-up services.
Pregnant women were excluded. Study partici-
pants were enrolled by the attending physician and
filled a self-administered questionnaire, which
included data on sociodemographic and lifestyle
indicators, reproductive and medical history and
sexual behaviour. Only few questions about sexual
behaviour were included, due to the sensitivity of
this issue among this population. The study was
approved by the Hamad Medical Corporation
Research Committee, and all participants signed
informed consent forms prior to enrolment in the
study.
Biological sample collection and laboratory
analysis
Endocervical swabs were collected by the attending
physician. DNA extraction was performed, fol-
lowed by PCR, using the commercially available
Chlamydia trachomatis Real-TM PCR kit (Sacace
Biotechnologies, Italy).
Data analysis
Cross-tabulations between the different background
variables, as well as the biomarker for C trachoma-
tis infection, and nationality (Qatari vs non-Qatari)
were performed in order to describe the
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characteristics of the study population. The prevalence of
C trachomatis was also stratified by the sociodemographic and
lifestyle indicators, reproductive and medical history factors and
sexual behaviour characteristics for the Qatari versus non-Qatari
women. The χ2 test or the Fisher’s exact test (for categorical
variables) and the student t test (for continuous variables) were
used to determine statistical significance in these associations.
ORs for bivariate associations between the background variables
and a positive C trachomatis test were derived using logistic
regression. IBM-SPSS (Statistical Packages for the Social
Sciences) V.21.0 was used for all statistical analyses. The statis-
tical significance was set at p<0.05.
RESULTS
A total of 377 women were enrolled in the study, out of whom
351 (37.9% Qataris, 62.1% non-Qataris) were tested for the
presence of C trachomatis in their specimens. The characteristics
of tested and non-tested women were compared. No significant
differences were found except for educational level (p=0.010),
where a higher percentage of those who took the test had a
college degree compared with those who did not. Table 1
describes the characteristics of the study population who were
tested for the presence of C trachomatis, stratified by nationality.
The mean age of the participants was 41.2 years, and the vast
majority (93.0%; 95% CI 90.3 to 95.7) were currently married.
The proportion of women with no educational attainment was
significantly higher (p<0.001) among Qataris (35.9%) com-
pared with non-Qataris (8.3%). Only a small fraction of the par-
ticipants smoked (5.8%; 95% CI 3.3 to 8.3). The vast majority
of the participants had children (95.7%; 95% CI 93.6 to 97.8);
72.5% of Qataris had more than four children compared with
37.2% of non-Qataris (p<0.001).
Almost all respondents reported no prior history of a sexually
transmitted disease; 7.4% (95% CI 4.7 to 10.3) had a family
history of cervical cancer; 92.6% (95% CI 89.7 to 95.4) were
not using oral contraceptives at the time of the study and 14.2%
(95% CI 10.5 to 18.0) had regular Pap smear tests, with no stat-
istically significant differences for these characteristics between
the two nationality groups. The mean age at sexual debut was
significantly lower among Qatari women (19.2 vs 22.2 years;
p<0.001), but the mean number of reported lifetime sexual
partners (1.1 partner) was nearly the same for both groups
(p=0.110). Less than 10% of these women reported more than
one lifetime sexual partner, and less than 1% had more than
two partners. Nineteen women tested positive for C trachomatis
indicating an overall prevalence of 5.4% (95% CI 3.0 to 7.8).
The prevalence of C trachomatis was 5.3% among Qatari
women and 5.5% among non-Qatari women, with no statistic-
ally significant difference between the two groups (p=0.923).
Analyses of ORs were conducted to identify the different socio-
demographic and lifestyle indicators, reproductive and medical
history factors and sexual behaviour characteristics associated with
a positive C trachomatis test. No statistically significant associa-
tions were found with any of the variables, probably reflecting the
small number of those who tested positive. We also found no stat-
istically significant differences in the prevalence of C trachomatis
stratified by the sociodemographic and lifestyle indicators, repro-
ductive and medical history factors and sexual behaviour charac-
teristics for the Qatari versus non-Qatari women.
DISCUSSION
We documented a considerable prevalence of C trachomatis
infection among women attending primary healthcare centres in
Qatar. The prevalence of about 5% is broadly comparable with
reported figures in the United Arab Emirates5 and Kuwait6
within the Arabian Gulf region, in other MENA countries,2 as
Table 1 Characteristics of the study population by nationality,
women attending women’s primary healthcare centres, Doha,
Qatar, 2008
Qatari
(N=133)
Non-Qatari
(N=218)
Total
(N=351)
p Valuen (%)* n (%)* n (%)*
Sociodemographic and lifestyle indicators
Age
20–29 14 (10.7) 35 (16.1) 49 (14.0)
30–39 33 (25.2) 67 (30.9) 101 (28.9)
40–49 54 (41.2) 74 (34.1) 128 (36.7)
≥50 30 (22.9) 41 (18.9) 71 (20.3) 0.221
Mean (SD) 42.45 (9.43) 40.52 (10.21) 41.24 (9.96) 0.079
Current marital status
Married 112 (86.2) 207 (97.2) 319 (93.0)
Non-married 18 (13.8) 6 (2.8) 24 (7.0) <0.001
Educational level
None 46 (35.9) 18 (8.3) 64 (18.6)
School 54 (42.2) 71 (32.9) 125 (36.3)
College 28 (21.9) 127 (58.8) 155 (45.1) <0.001
Smoking
Yes 4 (3.1) 16 (7.4) 20 (5.8)
No 126 (96.9) 200 (92.6) 326 (94.2) 0.095
Reproductive and medical history
Number of children
0 6 (4.6) 9 (4.1) 15 (4.3)
1–3 30 (22.9) 128 (58.7) 158 (45.3)
≥4 95 (72.5) 81 (37.2) 176 (50.4) <0.001
Mean (SD) 5.44 (3.05) 3.21 (1.93) 4.05 (2.64) <0.001
Previous miscarriage
0 72 (54.5) 131 (61.2) 203 (58.7)
1–2 45 (34.1) 69 (32.2) 114 (32.9)
≥3 15 (11.4) 14 (6.5) 29 (8.4) 0.227
Mean (SD) 0.95 (1.40) 0.69 (1.16) 0.79 (1.26) 0.056
Current oral contraceptive use
Yes 8 (6.2) 17 (8.2) 25 (7.4)
No 121 (93.8) 190 (91.8) 311 (92.6) 0.495
STD history
Yes 0 (0.0) 1 (0.5) 1 (0.3)
No 132 (100.0) 211 (99.5) 343 (99.7) 0.999
Frequency of Pap smear
Never 37 (28.9) 68 (32.5) 105 (31.2)
Regular 13 (10.2) 35 (16.7) 48 (14.2)
Irregular 78 (60.9) 106 (50.7) 184 (54.6) 0.118
Family history of cervical cancer
Yes 8 (6.1) 18 (8.3) 26 (7.4)
No 124 (93.9) 198 (91.7) 323 (92.6) 0.434
Sexual behaviour
Age of sexual debut
≤15 years 30 (23.3) 21 (10.0) 51 (15.0)
>15 years 99 (76.7) 190 (90.0) 289 (85.0) 0.001
Mean (SD) 19.91 (5.17) 22.15 (5.19) 21.31 (5.29) <0.001
Number of years since sexual debut
<10 24 (18.3) 58 (27.0) 82 (23.7)
10–19 38 (29.0) 79 (36.7) 117 (33.8)
20–29 42 (32.1) 46 (21.4) 88 (25.4)
≥30 27 (20.6) 32 (14.9) 59 (17.1) 0.026
Mean (SD) 19.92 (11.06) 17.00 (10.06) 18.08 (10.52) 0.012
Continued
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well as globally in North America,7 8 Europe,9 10 Asia,11 12
Oceania13 14 and sub-Saharan Africa.15 Nevertheless, the preva-
lence tends to be at the higher side of the global range particu-
larly in view of the average age of the participants. This finding
was not expected considering the prevailing sexually conserva-
tive norms and low reported sexual-risk behaviour in the
MENA region.2 16
This result, however, may not be interpreted as necessarily
higher than expected levels of sexual risk behaviour. The fact
that there are no formal C trachomatis screening programmes,
or any specific bacterial STIs prevention and treatment pro-
grammes, may have contributed to the higher prevalence. As
seen in other populations globally, limited active chlamydia
diagnosis and specific treatment can lead to surprisingly high
levels of prevalence, as a consequence of the asymptomatic
nature of this infection and its persistence for months or years if
untreated.17 18 The high sensitivity of the employed microbio-
logical assay may have also contributed to a higher positivity
rate,15 19 20 as well as the enforced restricted-access to antibio-
tics in Qatar in view of an ecological correlation between anti-
biotics use and lower prevalence.21 Since the study participants,
irrespective of their nationality, have access to the services
offered by the national healthcare system, it is not likely that dif-
ferences in access to healthcare can explain the difference in
prevalence among Qatari versus non-Qatari women. Regardless,
the difference was small and not statistically significant.
On the other hand, the observed prevalence suggests that risks
for acquiring the infection are present, though not necessarily
through the women’s own behaviour. The women likely acquired
the infection from their spouses, an observation supported by the
overall pattern of STIs in MENA.2 16 For example, although
women are estimated to account for 9% of people engaged in
high-risk behaviour in Morocco, they contribute to about 50%
of new HIV infections.22 Similarly, 97%23 and 76%24 25 of noti-
fied HIV-infected women in Saudi Arabia and Iran, respectively,
have acquired the infection from their husbands. In view of the
high mobility of the population in Qatar and the fact that more
than 70% are expatriates,4 the infection transmission networks
likely transcend the borders of this country.
We recruited women attending healthcare centres, and such a
population may not be representative of the female population
in Qatar. Reporting bias may have affected our study with the
stigma surrounding STIs in this population. Chlamydia preva-
lence tends to be low in general population groups, and the
employed PCR kit has not been validated in our study popula-
tion, thereby potentially undermining the positive predictive
value of the diagnostic test.26 With the small number of infec-
tions in the sample, and the few sexual behaviour measures col-
lected, our study also lacked an analytical design to examine
specific risk factors for the infection. The predictors of infection
and the age distribution of infection among these women could
strikingly be different from those in other settings given the dif-
ferences in sociocultural context and sexual networking. Future
studies on C trachomatis should consider larger sample sizes to
allow for identification of the predictors of infection and should
include testing for other STIs, such as gonorrhoea and herpes
simplex virus type 2. This will add key data to our knowledge
of STIs in this part of the world.
Despite these limitations, our study, the first of its nature in
Qatar, is an endeavour to examine a neglected disease burden in
spite of challenges limiting the conduct of such studies. Our find-
ings highlight a disease burden that is largely not being dealt
with, but should be addressed through targeted programmes for
sexual health and STIs for both women and men. Such pro-
grammes need to be culturally sensitive and gender-specific to be
acceptable and relevant, and should capitalise on the strengths of
MENA’s cultural traditions.27 Considering the modest contribu-
tion of our study to informing specific policy and programming,
further research on representative population samples and cost-
effectiveness analyses are needed before specific screening and
treatment programmes could be recommended. Opportunistic
targeted screening could be a meaningful starting point, with
potentially routine Pap smear testing as an entry point.
CONCLUSION
We documented higher than expected C trachomatis prevalence
in Qatar, possibly reflecting the limited specific diagnosis and
treatment programmes. Our study highlights how the disease
burden of STIs, even in a sexually conservative society, could be
significant with the lack of STI-specific programmes. Since mul-
tiple STIs are curable, including C trachomatis, detecting these
infections and linking them with appropriate treatment channels
could alleviate an unnecessary disease burden and its conse-
quences in the population.
Key messages
▸ We found higher than expected prevalence of Chlamydia
trachomatis infection among women attending primary
healthcare centres in Qatar, with no significant difference in
prevalence between Qatari nationals and expatriate
residents.
▸ The observed prevalence may reflect the limited access and
use of Chlamydia-specific screening and management.
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Table 1 Continued
Qatari
(N=133)
Non-Qatari
(N=218)
Total
(N=351)
p Valuen (%)* n (%)* n (%)*
Number of lifetime sexual partners
1 115 (89.8) 205 (96.2) 320 (93.8)
2 12 (9.4) 6 (2.8) 18 (5.3)
≥3 1 (0.8) 2 (0.9) 3 (0.9) 0.023
Mean (SD) 1.11 (0.34) 1.05 (0.30) 1.07 (0.31) 0.110
Chlamydia trachomatis infection
Chlamydia trachomatis results
Negative 126 (94.7) 206 (94.5) 332 (94.6) 0.923
Positive 7 (5.3) 12 (5.5) 19 (5.4)
NB: Numbers do not necessarily add up to the total because of missing values, and
numbers in bold represent significance at p<0.05.
STD, sexually transmitted disease.
*Column percentages.
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